“We just need as many bright dedicated minds in the game of creating new solutions to old problems. Finding the companies that can help us solve those problems, that’s what this Residency is really about.”
– Hugh Jones, Chief Strategy Officer, Northern Light Health
Partnering with Northern Light Health, MaineHealth, and Maine Venture Fund, the Roux Institute’s Future of Healthcare Founder Residency is transforming healthcare innovation.
As part of our Residency, you will get:
Exposure to two healthcare systems, serving 90% of the Maine population
The following companies are currently participating in our inaugural Future of Healthcare Founder Residency cohort, which launched in April 2023.
“If you are a healthcare venture, this is where you want to be.” – Jen Schlegel, Founder and CEO of 119
Althea Health
Althea Health is developing an artificial intelligence virtual healthcare assistant that aims to ease staffing and burnout faced by healthcare providers.
Apriqot
Apriqot is creating a “community magnifying glass” that produces dynamic population health estimates to help highlight the factors behind inequities in health outcomes and, ultimately, inform policy.
Empallo
Empallo is an MIT spinoff that is creating machine learning models that will ultimately produce more personalized treatment plans for patients with cardiovascular diseases and improve clinical trials.
EmTech Care Labs
EmTech Care Labs is developing a digital platform, Care-Wallet, to assist families in managing home-based long-term care.
Mother of Fact
Mother of Fact is a digital health platform provided to women’s health clinics that connect their patients with registered dieticians.
PragmaClin
PragmaClin is a cloud-based patient monitoring and assessment tool to help neurologists assess the progression of Parkinson’s Disease in their patients.
Radiolife
Radiolife is a startup developing a medical device called Cube Scan that can detect the presence of viruses, bacteria and even cancer cells in under 20 seconds.
Stratos Medical
Stratos Medical is an early stage company that is working on its first product, TrackSmart, a device that aims to make vascular access easier and less damaging during hemodialysis sessions.
119
119 is a communication tool designed to guide bystanders through the appropriate response in emergency situations.
Coredio
Coredio provides SaaS platform and algorithms for heart failure detection and management.
EmpoweRx Inc.
EmpoweRx is powering the future of healthcare staffing with entrepreneurship and technology.
Health For Mankind Company
Health For Mankind Company is developing Diabimetrics, an AI-powered, cost-effective diabetes management tool tailored for minorities, blending technology and culture for better health.
Legacy
Legacy automates advance care planning for better patient outcomes.
OPTT Health
OPTT Health is a technology company that leverages AI to support mental health care teams in delivering personalized, data-driven, and evidence-based care to patients.
Parrots Inc.
Parrots Inc. leverages advanced AI and machine learning technologies to develop an intuitive platform that enhances communication and cognitive support for individuals with neurological disorders.
Valhalla Healthcare
Valhalla is a next-generation clinical automation platform that streamlines medical office operations.
Novobeing
Novobeing is an immersive well-being platform that leverages virtual and mixed reality technologies to reduce stress and anxiety.
Metis Health Technologies
Metis is dedicated to advancing healthcare alignment for better outcomes, beginning with foundational measurement.
HUB Healthcare
HUB connects everyone so teams can deliver better care, faster.
Speak with a Future of Healthcare Founder Residency Program Leader about your company’s fit for 50,000 investment and how we can support your go to market.
Nancy Brown, MBA
General Partner at Oak HC/FT
Todd Haedrich
Chief Executive Officer at Optimize Health
Hugh Jones, MBA
CSO, Senior VP at Northern Light Health
Philip Licari, MBA
Entrepreneur In Residence at the Roux Institute; Part-time...
Ann Miller
Independent Director at Inovio Pharmaceuticals; Maine Angel
Jennifer Monti, MD
Cardiologist and Research Scientist at Meta
Lizzy Mulcahy
Director of Telehealth at MaineHealth
Joe Powers
Managing Director at Maine Venture Fund
Burak Sezen
Co-Founder and Partner, The 6ixth Event Capital
Sherry Smith
VP, Operational Transformation at AVIA
Tom Torre
CEO, Cofounder, and Board Member at bendHSA
David Wennberg
ret. Quartet Health, High Value Healthcare Collaborative, Health...
Jonathan Bush
Chief Executive Officer, Zus Health
Companies submit an initial application online. We review those applications and schedule due diligence interviews with the most promising companies. Once we have narrowed down applications, we engage subject-matter experts in a comprehensive process to identify finalists, who then pitch in front of our Advisory Committee for a spot in the program. We typically have an acceptance rate of ~10%.
We take a 5% common equity stake in each company (the same type of equity you have as a Founder). This is in exchange for a range of services and program benefits we provide, including the $50,000.
No, we do not. Whatever IP you bring to the program, you continue to own outright. In the event your company conducts research with Roux faculty or any of our partners, the terms of the IP would be dictated by a separate agreement.
We believe that healthcare is a specialized sector that requires a tailored approach to company growth. As opposed to a three-month sprint, we provide a full year to ensure the progress you need to grow your venture. We work hand-in-hand with you every day as an extension of your team, along with the in-house Business, Design, and Legal services we provide. We integrate deeply with our founding partners in the healthcare space to give you access to their networks and systems as well as ours.
